Life science executives: We can feel the lack of traveling salespeople

Novo Nordisk and Coloplast have both experienced the necessity of salespeople pitching products in person, whereas Teva's Kåre Schultz highlights differences in the markets.

Photo: Stine Bidstrup/ERH

Although virtual meetings have become more widespread, also when selling medicine, Danish pharmaceutical company Novo Nordisk's experience with launching diabetes tablet Rybelsus has shown that they are not sufficient, according to Danish newspaper Børsen.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs